You are here: Industry Insights > Merck

News List

Merck, Thermis collaborate to develop vaccines biospectrumasia
August 25, 2019
Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates
Merck invites applications for ’Merck Young Scientist Award’ expresspharma
August 23, 2019
The awards will be decided by well acclaimed jury from leading science organisations, academia from industry
Merck receives 7 additional CRISPR patents, bringing total to 20 worldwide biospectrumasia
August 20, 2019
Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for Merck's CRISPR genome-editing technology
AstraZeneca and Merck’s Lynparza continues to perform well in ovarian cancer pharmaceutical-technology
August 16, 2019
AstraZeneca and Merck have announced that Lynparza (olaparib), the primary product in their ongoing oncology collaboration, has performed better than the standard of care as a first line maintenance treatment for patients with ovarian cancer, regardless o
Oncologie, Merck to Evaluate Bavituximab in Combination with KEYTRUDA for Gastroesophageal Cancer americanpharmaceuticalreview
August 13, 2019
Oncologie has entered into a clinical collaboration agreement with Merck to evaluate the combination of Oncologie's investigational drug Bavituximab, an antibody that blocks the activity of phosphatidylserine (PS), and ...
Merck to Build $650M Biomanufacturing Plant in NC contractpharma
July 30, 2019
New 225,000 square foot facility to produce active ingredient for the Gardasil 9 vaccine.
Merck to build Gardasil 9 plant and add 425 jobs, but will cut 150 elsewhere fiercepharma
July 28, 2019
Merck’s Gardasil is not just a moneymaker, it is a job creator. Just weeks after announcing a Virginia expansion to produce the vaccine and add 100 jobs, the drugmaker says it will build a new plant for Gardasil in North Carolina with 425 more.
Eisai, Merck receive breakthrough therapy designation from FDA biospectrumasia
July 23, 2019
For LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Combination Treatment as Potential First-Line Treatment of Patients with Advanced Unresectable Hepatocellular Carcinoma Not Amenable to Locoregional Treatment
Merck and Broad Institute announce CRISPR license framework biospectrumasia
July 20, 2019
New framework simplifies and accelerates access to CRISPR intellectual property for research
With test, Merck takes temperature-controlled drug delivery by drone from remote idea to remote locations fiercepharma
July 13, 2019
Drugmakers have speculated about delivering temperature-sensitive vaccines and drugs to remote locations using drones. Now, Merck & Co. is testing the method.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page